Cynthia Sears
Infectious Disease · Baltimore, MDNPI 1558386995
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $15,245 of the $16,020 with a category attached, or 95.2%. 3 manufacturers reported payments, led by Sanofi Pasteur Inc. at 43.6% of the total.
Across 5 payments — averaging $3204.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$7K
- Merck$6K
- Ferring Pharmaceuticals Inc.$3K
Across 7 payments — averaging $201,468 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$1.4M
What the payments were for
- Consulting fees$15,24595%
- Travel & lodging$7455%
- Food & beverage$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 1 | $6,985 |
| Merck | 3 | $6,275 |
| Ferring Pharmaceuticals Inc. | 1 | $2,760 |
How this compares
$16,020 in reported general payments places this provider in the 85th percentile of 289 infectious disease providers in Maryland.
Other infectious disease in Baltimore
- Robert RedfieldBaltimore$779K
- Luciana BorioBaltimore$671K
- Mark SulkowskiBaltimore$240K
- Jonathan ZenilmanBaltimore$202K
- Robert EdelmanBaltimore$125K
- Kjell WibergBaltimore$113K
- Christine DurandBaltimore$53K
- Myron LevineBaltimore$51K
- Robert BollingerBaltimore$50K
- Richard BergBaltimore$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.